Live Chat ×
Skip to main content

Ask the Expert Webinar: Telehealth for Epilepsy Part 2: Putting Guidelines into Practice

Activity provided by the American Epilepsy Society
Recording Date: April 20, 2020
Release Date: May 18, 2020
Expiration Date: May 18, 2023

Please review all activity information below. To receive credit for this activity you must view the presentation and complete the evaluation.

Note: A downloadable PDF of the slide set is available under the "Resources Tab" of the presentation. 

This enduring activity is a free resource to members and non-members.

This enduring activity is presented in partnership with the 
Child Neurology Foundation.

Overview
This webinar provides insights and examples of telehealth clinic workflows that you can incorporate in your own patient care. Plus, hear more about recent updates for reimbursement on telehealth services, and ideas for engaging trainees and other multi-specialty partners in your telehealth visits.

Target Audience
Epileptologists, neurologists, advanced practice providers, nurses, allied health professionals, clinical trainee students, and fellows

Learning Objectives
Following participation in this activity, the learner should be able to:

  • Develop office workflow to maximize benefit of telehealth for patients
  • Summarize the latest information on reimbursement for telehealth services
  • Apply strategies for incorporating trainees and multi-specialty partners into a telehealth visit

Disclosure Policy

It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity and scientific rigor. All individuals involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. Conflicts of interest will be resolved by AES prior to an educational activity being delivered to learners.

Faculty, Planning Committee, Reviewers’ Disclosures of Financial Relationships
In accordance with the ACCME Standards for Commercial Support, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with a commercial interest. The following individuals contributed to this activity’s content.

Planners
Barbara C. Jobst, MD, PhD, Dartmouth Hitchcock Medical Center, Lebanon, NH
Dr. Jobst has disclosed the following relevant relationships:
Research support from the following entities: Neuropace; Medtronic; Eisai; Harvard Pilgrim; NIH; CDC; NSF; DARPA; and Editor of Neurology and Epilepsia

Fred A. Lado, MD, PhD, Northwell Health, Great Neck, NY
Dr. Lado has indicated he has no financial relationships to disclose relevant to this activity.

Moderator
David Ficker, MD, Chair, Webinar Workgroup, Cincinnati Medical Center, Cincinnati, OH
Dr. Ficker has disclosed the following relevant relationships:
Greenwich Biosciences (speaker); and Best Doctors Inc. (consultant)

Presenters
Christopher Peterson, DPT, PT, Hartford HealthCare, Hartford, CT
Dr. Peterson has indicated he has no financial relationships to disclose relevant to this activity.

Edward “Rusty" J. Novotny, Jr., MD, FAAN, University of Washington School of Medicine, Seattle, WA
Dr. Novotny has indicated he has no financial relationships to disclose relevant to this activity.

Marvin A. Rossi, MD, PhD, Rush University Medical Center, Chicago, IL
Dr. Rossi has disclosed the following relevant relationships:
CDBG; Foglia Family Foundation; Adelaide Cervantes Epilepsy Fund; and UCB

Anup D. Patel, MD, Nationwide Children's Hospital, Columbus, OH
Dr. Patel has indicated he has no financial relationships to disclose relevant to this activity.

Holly Paauwe, Parent, Creator of Hemimegalencephaly (HME) Family Support Network, and HME Specialty Director of The Hemispherectomy Foundation
Ms. Paauwe has indicated she has no financial relationships to disclose relevant to this activity.

Katie Hentges, Director, Programs, Child Neurology Foundation
Ms. Hentges has indicated she has no financial relationships to disclose relevant to this activity.

Panelist

Gabriel U. Martz, MD, Hartford HealthCare, Hartford, CT
Dr. Martz has indicated he has no financial relationships to disclose relevant to this activity

CME Reviewer
Jay Salpekar, MD, Kennedy Krieger Institute, Baltimore, MD
Dr. Salpekar has disclosed the following relevant relationships:
Lundbeck: Investigator initiated study- research funding to institution only; contracted research

American Epilepsy Society Staff Planners
Amy Kephart, MPH, American Epilepsy Society, Chicago, IL
Ms. Kephart has indicated she has no financial relationships to disclose relevant to this activity.

Cristina Graham, American Epilepsy Society, Chicago, IL
Ms. Graham has indicated she has no financial relationships to disclose relevant to this activity.

Resolution of Conflicts of Interest
It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. In accordance with the ACCME Standards for Commercial Support of CME, the AES implemented the mechanisms of prospective peer review of this CME activity, to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence.

Accreditation
The American Epilepsy Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

For more information regarding contact hours, please call American Epilepsy Society 312.883.3800.

Credit Designation
The American Epilepsy Society designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Credits: The American Medical Association has determined that non-US. licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

CME Certificate

To receive credit for your participation in this activity, please complete the evaluation survey provided at the conclusion of the activity.

Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.

Disclaimer
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational and/or experimental uses.